Arthrohelp s.r.o.
- Address
- lock Available on a paid plan
Immune System Diseases at Arthrohelp s.r.o.
Clinical research at this hospital/clinic in Pardubice focuses on immune system diseases, with studies centered on psoriatic arthritis and rheumatoid arthritis. The trials are designed to assess whether newer therapies can better control joint inflammation, reduce symptoms, and improve treatment options for people living with these chronic conditions.
- Evaluating new treatment approaches for active psoriatic arthritis
- Studying therapy options for psoriatic arthritis in patients with prior treatment challenges
- Assessing treatment effectiveness and safety in rheumatoid arthritis
This research reflects a focused effort to improve care in rheumatology, especially by comparing emerging medicines with established options and placebo to better understand their benefits for patients.
Psoriatic Arthritis Research
A major part of the site’s trial activity involves psoriatic arthritis, including active psoriatic arthritis and cases where previous treatments have not worked well enough. These studies aim to test whether newer therapies can reduce pain, swelling, and other signs of disease more effectively than current approaches.
- Testing a new therapy for active psoriatic arthritis
- Exploring options for patients with inadequate response or intolerance to prior treatment
- Measuring improvement in signs and symptoms of disease
The work at Arthrohelp s.r.o. helps build evidence for more personalized care in inflammatory arthritis, with an emphasis on finding effective alternatives for patients who need better disease control.
Rheumatoid Arthritis Studies
The site also contributes to research in rheumatoid arthritis, a long-term autoimmune condition that can cause joint pain, stiffness, and disability. The trial activity in this area is aimed at evaluating how well treatment strategies work and how they may improve everyday outcomes for patients.
- Comparing treatment options for rheumatoid arthritis
- Assessing safety and effectiveness of therapy
- Supporting better management of chronic inflammatory joint disease
With a small but focused portfolio, the research team is contributing to ongoing efforts in rheumatology to refine treatment choices and improve care for people with immune-mediated joint disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Arthrohelp s.r.o.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Placebo-Controlled, Double-Blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult Subjects with Axial Spondyloarthritis Followed by a Remission-Withdrawal Period | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Mar 2020 | Apr 2024 |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abt-494 | 1 | Unknown | 2020-03-23 | 2020-03-23 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.